Constructing an efficient trans-acting genomic HDV ribozyme

FEBS Lett. 1996 Sep 30;394(2):132-6. doi: 10.1016/0014-5793(96)00941-6.

Abstract

We have engineered a genomic HDV ribozyme to construct several trans-acting ribozymes for use in trans to cleave target RNAs. Among the 10 different combinations attempted, only HDV88-Trans had cleavage activity on the 13-nucleotide substrate, R13, in vitro. To improve the cleavage efficiency, at least in vitro, of the HDV88-Trans ribozyme (kclv = 0.022 min(-1)), we have constructed several variants that differ in forming stem II (length) in the pseudoknot secondary structure model. When cleavage rate constants were analyzed and compared among variants of HDV88-Trans, HDV88-Trans-4 yielded kclv = 1.7 min(-1). HDV88-Trans-4 thus represents the highest active genomic HDV ribozyme that functions in trans thus far constructed, and has activity under physiological conditions (pH 7.1 at 37 degrees C with 1 mM of MgCl2).

MeSH terms

  • Base Sequence
  • DNA Primers
  • Enzyme Activation
  • Genetic Engineering
  • Genome, Viral
  • Hepatitis Delta Virus / enzymology*
  • Hepatitis Delta Virus / genetics
  • Kinetics
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Nucleic Acid Conformation
  • RNA, Catalytic / chemistry
  • RNA, Catalytic / genetics*
  • RNA, Catalytic / metabolism*
  • RNA, Viral / chemistry
  • RNA, Viral / genetics
  • RNA, Viral / metabolism*

Substances

  • DNA Primers
  • RNA, Catalytic
  • RNA, Viral